Scott J. Harvey, PhD
Avenir Laureate, Inserm U574
Equipe 'miRNAs in kidney development and function'

Publications

Peer-Reviewed Articles

  • Larsson E, Fredlund-Fuchs P, Bondjers C, Barkefors I, Heldin J, Gerwins P, Genove G, Arrondel C, Harvey SJ, Kreuger J, Lindahl P. Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1.  Genome Med. 1(11):108, 2009

  • Ratelade J, Arrondel C, Hamard G, Garbay S, Harvey S, Biebuyck N, Schulz H, Hastie N, Pontoglio M, Gubler MC, Antignac C, Heidet L.. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes. Human Molecular Genetics (in press)

  • Goldberg S, Harvey SJ, Cunningham J, Tryggvason K, Miner JH. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane. Nephrol Dial Transplant. 24(7):2044-2051, 2009

  • Harvey SJ, Jarad G, Cunningham J, Goldberg S, Schermer B, Harfe BD, McManus MT, Benzing T, Miner JH. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol. 19(11):2150-2158, 2008

  • Harvey SJ, Jarad G, Cunningham J, Rops A, van der Vlag J, Berden JH, Moeller M, Holzman L, Burgess RW, Miner JH. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol 171(1):139-152, 2007

  • Shannon MB, Patton BL, Harvey SJ, Miner JH. A hypomorphic mutation in the mouse laminin a5 gene (Lama5) causes polycystic kidney disease. J Am Soc Nephrol. 17(7):1913-1922, 2006

  • Harvey SJ, Perry J, Zheng K, Chen D, Sado Y, Jefferson B, Ninomiya Y, Jacobs R, Hudson BG, Thorner PS. Sequential expression of type IV collagen networks: Testis as a model and relevance to spermatogenesis. Am J Pathol. 168(5):1587-1597, 2006

  • Zheng K, Perry J, Harvey SJ, Sado Y, Ninomiya Y, Jefferson B, Jacobs R, Hudson BG, Thorner PS. Regulation of collagen type IV genes is organ-specific: Evidence from a canine model of Alport syndrome. Kidney Int. 68(5):2121-2130, 2005 

  • Gross O*, Beirowski B*, Harvey SJ*, McFadden C, Chen D, Tam S, Thorner PS, Smyth N, Addicks K, Bloch W, Ninomiya Y, Sado Y, Weber M, Vogel WF. DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria. Kidney Int. 66(1):102-111, 2004  (* equal contribution)

  • Harvey SJ, Zheng K, Jefferson B, Moak P, Sado Y, Naito I, Ninomiya Y, Jacobs R, Thorner PS. Transfer of the a5(IV) collagen chain gene to smooth muscle restores in vivo expression of the a6(IV) collagen chain in a canine model of Alport syndrome. Am J Pathol. 162(3): 873-885, 2003 

  • Chen D, Jefferson B, Harvey SJ, Stephens D, Jacobs RM, Thorner PS. Cyclosporine A slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): Results from a canine model. J Am Soc Nephrol. 14(3):690-698, 2003 

  • Harvey SJ, Mount R, Sado Y, Naito I, Ninomiya Y, Harrison R, Jefferson B, Jacobs R, Thorner PS. The inner ear of dogs with X-linked nephritis provides clues to the pathogenesis of hearing loss in X-linked Alport syndrome. Am J Pathol. 159(3):1097-1104, 2001 

  • Morello R, Zhou G, Dreyer SD, Harvey SJ, Ninomiya Y, Thorner PS, Miner JH, Cole W, Winterpacht A, Zabel B, Oberg KC, Lee B. Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome. Nat Genet. 27(2):205-208, 2001 

  • Zheng K, Harvey S, Sado Y, Naito I, Ninomiya Y, Jacobs R, Thorner PS. Absence of the a6 chain of collagen type IV in Alport syndrome is related to a failure at the level of protein assembly and does not result in diffuse leiomyomatosis. Am J Pathol. 154(6):1883-1891, 1999 

  • Harvey SJ, Zheng K, Sado Y, Naito I, Ninomiya Y, Jacobs RM, Hudson BG, Thorner PS. Role of distinct type IV collagen networks in glomerular development and function. Kidney Int. 54(6):1857-1866, 1998 

Book Chapters & Commentaries

  • Saal S, Harvey SJ. MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens. 18(4):317-323, 2009

  • Gross O, Borza DB, Anders HJ, Licht C, Weber M, Segerer S, Torra R, Gubler MC, Heidet L, Harvey S, Cosgrove D, Lees G, Kashtan C, Gregory M, Savige J, Ding J, Thorner P, Abrahamson DR, Antignac C, Tryggvason K, Hudson B, Miner JH. Stem cell therapy for Alport syndrome: the hope beyond the hype. Nephrol Dial Transplant. 24(3):731-734, 2009

  • Harvey SJ, Miner JH. Revisiting the glomerular charge barrier in the molecular era. Curr Opin Nephrol Hypertens 17:393-398, 2008

  • Harvey SJ, Miner JH. Breaking down the barrier: Evidence against a role for heparan sulfate in glomerular permselectivity. J Am Soc Nephrol. 18(3):672-674, 2007

  • Harvey SJ and Thorner PS. (2005) Type IV collagen: A network for development, differentiation and disease. In: Advances in Developmental Biology. Extracellular Matrix in Development and Disease, ed. Miner JH. Elsevier, Vol. 15, p. 1-64